4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Unicycive Therapeutics, Inc. (UNCY) operates in the Biotechnology industry and is headquartered in Mountain View, United States with about 21 employees. Its market capitalization is roughly $144 million. In the fiscal year ended 2025-12-31, UNCY reported $0M in revenue and ($27M) in net income.
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $1M | $1M | — |
| Operating Income (EBIT) | ($30M) | ($32M) | ($21M) | ($18M) | — |
| Net Income | ($27M) | ($37M) | ($30M) | ($18M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($8M) | ($7M) | ($7M) | ($7M) | ($8M) | — |
| Net Income | ($13M) | ($15M) | ($6M) | ($6M) | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | $0M | ($1M) | $0M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | — | $0M | $0M | — | — | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $49M | $32M | $14M | $3M | — |
| Total Liabilities | $19M | $24M | $18M | $3M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive UNCY viewer.
About TickerBase · Data methodology & sources